These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34218118)

  • 1. Erratum to "Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists" [Bioorg. Med. Chem. Lett. 47 (2021) 128172].
    Zhang X; Zhu B; Guo L; Bakaj I; Rankin M; Ho G; Kauffman J; Lee SP; Norquay L; Macielag M
    Bioorg Med Chem Lett; 2021 Sep; 47():128232. PubMed ID: 34218118
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to "Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes" Bioorg. Med. Chem. Lett. 28 (2018) [841-846].
    Winters MP; Sui Z; Wall M; Wang Y; Gunnet J; Leonard J; Hua H; Yan W; Suckow A; Bell A; Clapper W; Jenkinson C; Haug P; Koudriakova T; Huebert N; Murray WV
    Bioorg Med Chem Lett; 2018 May; 28(9):1676-1678. PubMed ID: 29605534
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum to "A triple exon-skipping luciferase reporter assay identifies a new CLK inhibitor pharmacophore" [Bioorg. Med. Chem. Lett. 27 (2017) 406-412].
    Shi Y; Park J; Lagisetti C; Zhou W; Sambucetti LC; Webb TR
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1488-1489. PubMed ID: 28214076
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors" [Bioorg. Med. Chem. Lett. 60 (2022) 128549].
    Ma B; Metrick CM; Gu C; Hoemberger M; Bajrami B; Bame E; Huang J; Mingueneau M; Murugan P; Nevalainen M; Santoro JC; Tang H; Wang T; Hopkins BT
    Bioorg Med Chem Lett; 2022 Sep; 72():128856. PubMed ID: 35728998
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core" [Bioorg. Med. Chem. Lett. 26 (2016) 5399-5402].
    Han M; Wang C; Ji Y; Song Z; Xing L; Su Y; Wang X; Zhang A; Ai J; Geng M
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126931. PubMed ID: 31902709
    [No Abstract]   [Full Text] [Related]  

  • 7. Erratum to "Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors" [Bioorg. Med. Chem. 24 (2016) 3083-3092].
    Wang SB; Cui MT; Wang XF; Ohkoshi E; Goto M; Yang DX; Li L; Yuan S; Morris-Natschke SL; Lee KH; Xie L
    Bioorg Med Chem; 2017 May; 25(9):2676-2678. PubMed ID: 28363445
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535].
    Hartung AM; Navarro HA; Wiemer DF; Neighbors JD
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1645. PubMed ID: 28750745
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].
    Maryanoff BE
    Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives" [Bioorg Med Chem Lett 27(16) (2017) 3920-3924].
    Suzuki S; Sugawara Y; Tsuji R; Tanimura R; Kaneko C; Yuzawa N; Yagi M; Kawai K
    Bioorg Med Chem Lett; 2019 Feb; 29(3):515. PubMed ID: 30579796
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA
    Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of amide-based EP3 receptor antagonists.
    Lee EC; Futatsugi K; Arcari JT; Bahnck K; Coffey SB; Derksen DR; Kalgutkar AS; Loria PM; Sharma R
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2670-5. PubMed ID: 27107947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum to "Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase" [Bioorg. Med. Chem. 24 (2016) 4281-4290].
    Zhao F; Zhang J; Zhang L; Hao Y; Shi C; Xia G; Yu J; Liu Y
    Bioorg Med Chem; 2017 May; 25(10):2811-2812. PubMed ID: 28389111
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Rotenoisin A is a novel anti-adipogenic compound" [Bioorg. Med. Chem. Lett. 29 (2018) 89-96].
    Cho HH; Park HS; Jang SH; Won C; Kim HD; Kim TH; Cho JH
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127295. PubMed ID: 32571641
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390].
    Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Syntheses and antimicrobial activities of ogipeptin derivatives" [Bioorg. Med. Chem. Lett. 42 (2021) 128093].
    Takiguchi S; Homma H; Fujisawa T; Hirota-Takahata Y; Ono Y; Kizuka M; Ishii Y; Yoshimura S; Nishi T
    Bioorg Med Chem Lett; 2021 Sep; 47():128228. PubMed ID: 34192636
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Novel NanoLuc-type substrates with various C-6 substitutions" [Bioorg. Med. Chem. Lett. 30 (2020) 127085].
    Yan C; Du L; Li M
    Bioorg Med Chem Lett; 2021 May; 39():127940. PubMed ID: 33677042
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Investigation of biaryl heterocycles as inhibitors of Wee1 kinase" [Bioorg. Med. Chem. Lett. 29 (2019) 1481-1486].
    Mastracchio A; Lai C; Torrent M; Bromberg K; Buchanan FG; Ferguson D; Bontcheva V; Johnson EF; Lasko L; Maag D; Shoemaker AR; Penning TD
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126895. PubMed ID: 31926787
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Dimeric sesquiterpene and thiophenes from the roots of Echinops latifolius" [Bioorg. Med. Chem. Lett. 26 (2016) 5995-5998].
    Jin Q; Lee JW; Jang H; Choi JE; Kim HS; Lee D; Hong JT; Lee MK; Hwang BY
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1490. PubMed ID: 28202326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.